QQ客服 官方微博 反馈留言

	Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase.
	Xu L; Zhu H; Hu J; Wu D; Jiang H; Jiang Q; Huang X
刊名	Front Med
	2015
卷号	Vol.9 No.3
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1841276
专题	四川大学
作者单位	1.Jiang, Qian 2.Jiang, Hao 3.[Xu, Lanping 4.Huang, Xiaojun] Peking Univ, Peking Univ Peoples Hosp, Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing 100044, Peoples R China. [Zhu, Huanling] Sichuan Univ, West China Hosp, Chengdu 610041, Peoples R China. [Hu, Jianda] Fujian Med Univ, Union Hosp, Fujian Inst Hematol, Fuzhou 350001, Peoples R China. [Wu, Depei] Soochow Univ, Affiliated Hosp 1, Suzhou 215006, Peoples R China.
推荐引用方式 GB/T 7714	Xu L,Zhu H,Hu J,et al. Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase.[J]. Front Med,2015,Vol.9 No.3.
APA	Xu L.,Zhu H.,Hu J.,Wu D.,Jiang H.,...&Huang X.(2015).Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase..Front Med,Vol.9 No.3.
MLA	Xu L,et al."Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase.".Front Med Vol.9 No.3(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。